Cancer News
Possible decreased fertility risk for ovarian cancer patients
An innovative study showed that there is a risk of a possible decreased fertility in ovarian cancer patients treated with radioactive iodine treatment.
New drug for multiple myeloma closer to EU conditional approval
European regulators have recommended conditional approval for daratumumab, an immunotherapy treatment for multiple myeloma.
Adding vemurafenib to cobimetinib: beneficial against melanoma
Cobimetinib in combination with vemurafenib found to be even more beneficial than cobimetinib alone for melanoma patients, a new study reports.
Men with advanced melanoma benefited by dabrafenib/trametinib combo
A new analysis reveals that men with advanced melanoma benefited from a combination treatment of dabrafenib and trametinib.
Childhood cancer survivor and parent: more likely for women
Female childhood cancer survivors are more likely to have children than male survivors, a new study reveals.
Healthy breast removal won’t increase survival in breast cancer
Removing the second, healthy breast rose from 4% in breast cancer patients in 2002 to nearly 13% in 2012. However, this removal will not reduce the risk of dying.
PET/CT-guided surveillance promising in head and neck cancer
Patients with head and neck cancer who underwent PET/CT-guided surveillance or planned neck dissection had similar survival rates.
Is it possible to treat hard-to-treat cancers with targeted therapy?
Targeted therapy options can treat difficult to treat cancer tumors regardless of where tumor first originated with genomic profiling, a new study reveals.
Survival benefit in prostate cancer with abiraterone acetate
Abiraterone acetate increased overall survival in men with early and less aggressive chemotherapy-naïve metastatic castration-resistant prostate cancer.
Genomic test helps early breast cancer patients avoid chemo
Genomic testing can be used to help accurately select early breast cancer patients who can safely be spared chemotherapy, a new study shows.
US approval of crizotinib for metastatic non-small cell lung cancer
US regulators approved crizotinib capsules for the treatment of metastatic non-small cell lung cancer.
Neurofeedback against chemotherapy-induced neuropathy
Cancer patients experiencing chemotherapy-induced neuropathy after chemotherapy improved their quality of life and reduced pain using neurofeedback.
Improved survival in breast cancer with 'dose-dense' chemo
A meta-analysis revealed that dose-dense adjuvant chemotherapy significantly improved overall survival in premenopausal women with breast cancer.
Breast cancer tumors shrunk with lapatinib and trastuzumab combo
Tumors of breast cancer patients either shrunk or disappeared after treatment with a combination of lapatinib and trastuzumab.
Less breast cancer side effects with partial radiotherapy
Focusing postoperative radiotherapy around tumor containing cells has fewer long-term side effects and low recurrence rate in breast cancer patients.
Linking early stage breast cancer and high white blood cell ratio
A retrospective study reports that a high white blood cell ratio in early stage breast cancer patients is linked to an increased risk of disease recurrence.
Double mastectomy: not the best option for breast cancer patients
A new study reports that undergoing double mastectomy did not improve the quality of life of breast cancer patients.
Bladder cancer patients at risk due to blood clots
Bladder cancer patients who underwent surgery were found to be at risk due to blood clots formed in their vein after hospital discharge.
RFA complemented immunotherapy in colorectal cancer patients
RFA was found to complement immunotherapy and induce systemic antitumor responses in colorectal cancer patients with liver metastasis.
Tracking tumor DNA in the blood reveals skin cancer relapse
Scientists were able to see whether a patient with advanced melanoma skin cancer is relapsing by tracking levels of circulating tumor DNA in the blood.
Location of prostate cancer metastasis affects survival
A new large study reported that the location where prostate cancer spreads has an impact on the patient’s survival time.
Docetaxel plus ramucirumab show promise in urothelial cancer
Advanced urothelial cancer patients treated with ramucirumab plus docetaxel as second-line treatment reduced disease progression risk, a new study shows.
The importance of mapping a patient’s family health history
Mapping a patient’s family health history helped identify at-risk patients leading them to timely screening while saving others from unnecessary monitoring tests.
Linking the number of moles with tumor thickness in melanoma
A new study of the association between moles and tumor thickness found that having less moles is associated with reduced risk for thick melanoma.
Unraveling melanoma diagnosis and treatments
Melanoma rates have doubled although today we have more tools than even to diagnose melanoma, including genetic and molecular testing.
Obinutuzumab gets FDA’s green light for follicular lymphoma
US regulators have approved obinutuzumab in combination with bendamustine followed by obinutuzumab monotherapy for the treatment of patients with follicular lymphoma.
Childhood Hodgkin's lymphoma survivors are at risk of breast cancer
Childhood Hodgkin's lymphoma survivors are at risk of breast cancer say researchers, adding that early screening reduces risk of breast cancer death.
Empowering cancer patients with education on genomics
Patients of advanced lung or colorectal cancer want to receive better information on genomics and DNA sequencing results, a new study shows.
Palbociclib gets early FDA approval for breast cancer
US regulators approved earlier than scheduled palbociclib in combination with fulvestrant for the treatment of some cases of breast cancer.
Depression influences patient’s complications after cancer surgery
Cancer patients with symptoms of depression before undergoing a complex abdominal surgery are more likely to have postoperative complications, a study finds.